Medicine Supply Notification: Mirtazapine 15mg and 45mg orodispersible tablets

Medicine Supply Notification: Mirtazapine 15mg and 45mg orodispersible tablets

June 25, 2020

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Mirtazapine 15mg and 45mg orodispersible tablets.

Mirtazapine 15mg and 45mg orodispersible tablets are out of stock until late July 2020.

Mirtazapine 30mg orodispersible tablets remain available, but cannot support an increased demand.

Mirtazapine 15mg, 30mg and 45mg tablets remain available.

Unlicensed orodispersible tablets are available, and lead times will vary.

There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems so an EPS prescription for unlicensed mirtazapine (strength) orodispersible tablets cannot be issued. Where a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘Mirtazapine (strength) orodispersible tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special with the following information:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

 



Posted in: ,


More Latest News >